Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Ligand Pharmaceuticals - 32 Year Stock Price History | LGND

Historical daily share price chart and data for Ligand Pharmaceuticals since 1992 adjusted for splits and dividends. The latest closing stock price for Ligand Pharmaceuticals as of September 06, 2024 is 101.14.
  • The all-time high Ligand Pharmaceuticals stock closing price was 274.49 on September 28, 2018.
  • The Ligand Pharmaceuticals 52-week high stock price is 112.12, which is 10.9% above the current share price.
  • The Ligand Pharmaceuticals 52-week low stock price is 49.24, which is 51.3% below the current share price.
  • The average Ligand Pharmaceuticals stock price for the last 52 weeks is 75.84.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Ligand Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 83.2704 72.3100 110.1100 68.5300 101.1400 41.61%
2023 67.6952 66.0300 79.3300 49.5700 71.4200 6.92%
2022 94.5155 151.5600 151.5600 62.0000 66.8000 -56.75%
2021 139.1143 101.0700 215.8300 99.5200 154.4600 55.31%
2020 98.3573 104.7400 126.7200 63.3700 99.4500 -4.64%
2019 111.6805 137.0000 142.4700 86.2500 104.2900 -23.15%
2018 187.6862 138.6300 274.4900 128.3600 135.7000 -0.90%
2017 120.9272 102.5000 147.0400 100.3800 136.9300 34.76%
2016 108.9749 102.4700 138.5300 85.7900 101.6100 -6.28%
2015 86.5684 53.7300 111.8500 51.5400 108.4200 103.76%
2014 59.1922 51.5200 79.5800 42.3600 53.2100 1.16%
2013 37.1462 20.7200 57.9500 19.1602 52.6000 153.62%
2012 15.9545 11.9100 21.5300 11.4900 20.7400 74.73%
2011 11.4795 8.9900 15.9500 8.6500 11.8700 33.07%
2010 9.8156 13.0200 13.0200 8.2700 8.9200 -31.49%
2009 15.3079 16.2000 18.9000 9.9600 13.0200 -20.80%
2008 19.3233 29.1600 29.1600 7.6200 16.4400 -43.27%
2007 40.0625 49.1926 58.5712 23.4000 28.9800 -41.30%
2006 49.4716 51.8529 62.2356 35.8461 49.3730 -1.79%
2005 37.0503 50.5002 52.5292 21.4175 50.2748 -4.21%
2004 64.4892 67.3186 108.3049 35.4403 52.4841 -20.76%
2003 48.4792 24.6639 72.6842 16.8184 66.2364 173.56%
2002 51.9901 76.8775 90.1338 22.1389 24.2130 -70.00%
2001 54.3123 61.9980 85.6700 35.3952 80.7101 27.86%
2000 63.8520 62.5842 114.7076 44.3680 63.1252 8.70%
1999 44.1596 50.4551 62.8547 29.5787 58.0752 10.75%
1998 53.9537 57.4891 72.7293 25.9264 52.4390 -9.71%
1997 60.3340 69.2574 82.5588 41.1667 58.0752 -13.44%
1996 59.4135 46.8029 85.6700 46.2167 67.0931 38.42%
1995 35.4426 36.0716 49.5984 24.7992 48.4712 30.30%
1994 53.3798 54.1074 64.2525 28.1809 37.1988 -29.79%
1993 46.0966 55.2346 55.2346 39.4533 52.9801 11.90%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.884B $0.131B
Ligand, being a biotechnology company, focuses on developing/acquiring royalty revenue generating assets and coupling them with a lean corporate cost structure. Ligand's Captisol formulation technology has allowed it to enter into several licensing deals and generate royalties. Captisol is a well validated chemically modified cyclodextrin that is designed to improve safety and solubility, stability, and bioavailability or lessen the volatility, irritation, smell or taste of drugs. Ligand has merged with CyDex. By this, it added an antibody-generating platform, OmniAb, to the company's portfolio. Its other technology platforms include antigen discovery platform & protein expression platform. All these technologies have created a strong platform for Ligand to seek new licenses and partnerships. Ligand has partnership agreements with leading healthcare companies like Novartis, Amgen, Merck, Pfizer, Celgene, Gilead & Lilly, etc. The company continues to buy smaller companies to increase its technology platforms.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $174.288B 17.44
Regeneron Pharmaceuticals (REGN) United States $126.831B 29.95
Vertex Pharmaceuticals (VRTX) United States $120.939B 0.00
Bristol Myers Squibb (BMY) United States $100.964B 36.35
CSL (CSLLY) Australia $99.579B 0.00
Gilead Sciences (GILD) United States $98.068B 16.76
GSK (GSK) United Kingdom $89.388B 10.37
Argenex SE (ARGX) Netherlands $32.798B 0.00
Alnylam Pharmaceuticals (ALNY) United States $32.285B 0.00
Biogen (BIIB) United States $29.395B 12.41
Moderna (MRNA) United States $28.230B 0.00
BioNTech SE (BNTX) Germany $21.435B 0.00
Illumina (ILMN) United States $20.671B 141.04
BeiGene (BGNE) Cayman Islands $18.588B 0.00
Genmab (GMAB) Denmark $18.313B 22.88
BioMarin Pharmaceutical (BMRN) United States $16.163B 47.82
Sarepta Therapeutics (SRPT) United States $12.757B 290.80
Insmed (INSM) United States $12.530B 0.00
Vaxcyte (PCVX) United States $12.511B 0.00
Incyte (INCY) United States $12.126B 787.00
Bio-Techne Corp (TECH) United States $11.478B 44.95
Exact Sciences (EXAS) United States $11.254B 0.00
QIAGEN (QGEN) Netherlands $10.150B 21.43
Legend Biotech (LEGN) United States $9.854B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.108B 30.17
Roivant Sciences (ROIV) United Kingdom $9.015B 0.00
Repligen (RGEN) United States $8.130B 124.08
Halozyme Therapeutics (HALO) United States $7.734B 20.35
Intra-Cellular Therapies (ITCI) United States $7.652B 0.00
Exelixis (EXEL) United States $7.294B 22.43
Ascendis Pharma (ASND) Denmark $6.930B 0.00
Cytokinetics (CYTK) United States $6.581B 0.00
Zealand Pharma (ZLDPF) Denmark $6.392B 0.00
Viking Therapeutics (VKTX) United States $6.137B 0.00
Blueprint Medicines (BPMC) United States $5.790B 0.00
Nuvalent (NUVL) United States $5.505B 0.00
Krystal Biotech (KRYS) United States $5.346B 357.81
Ultragenyx Pharmaceutical (RARE) United States $5.203B 0.00
Immunovant (IMVT) United States $4.921B 0.00
Apellis Pharmaceuticals (APLS) United States $4.784B 0.00
Avidity Biosciences (RNA) United States $4.476B 0.00
Axsome Therapeutics (AXSM) United States $4.450B 0.00
Alkermes (ALKS) Ireland $4.423B 15.53
ADMA Biologics Inc (ADMA) United States $3.902B 64.39
CRISPR Therapeutics AG (CRSP) Switzerland $3.848B 0.00
Arcellx (ACLX) United States $3.783B 0.00
Denali Therapeutics (DNLI) United States $3.615B 0.00
Biohaven (BHVN) United States $3.491B 0.00
Amicus Therapeutics (FOLD) United States $3.467B 0.00
Merus (MRUS) Netherlands $3.436B 0.00
IDEAYA Biosciences (IDYA) United States $3.157B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.076B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.019B 0.00
Guardant Health (GH) United States $2.993B 0.00
SpringWorks Therapeutics (SWTX) United States $2.980B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.951B 0.00
Iovance Biotherapeutics (IOVA) United States $2.927B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.912B 0.00
Celldex Therapeutics (CLDX) United States $2.882B 0.00
Kymera Therapeutics (KYMR) United States $2.878B 0.00
Bavarian Nordic (BVNRY) Denmark $2.743B 14.81
ACADIA Pharmaceuticals (ACAD) United States $2.691B 90.11
Geron (GERN) United States $2.580B 0.00
CG Oncology (CGON) United States $2.519B 0.00
Myriad Genetics (MYGN) United States $2.512B 0.00
Protagonist Therapeutics (PTGX) United States $2.475B 16.04
ImmunityBio (IBRX) United States $2.403B 0.00
Twist Bioscience (TWST) United States $2.345B 0.00
Vericel (VCEL) United States $2.309B 0.00
Janux Therapeutics (JANX) United States $2.280B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $2.196B 0.00
Structure Therapeutics (GPCR) United States $2.195B 0.00
Apogee Therapeutics (APGE) United States $2.171B 0.00
Intellia Therapeutics (NTLA) United States $2.126B 0.00
Vera Therapeutics (VERA) United States $2.092B 0.00
NeoGenomics (NEO) United States $2.077B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.021B 18.24
Keros Therapeutics (KROS) United States $2.014B 0.00
Beam Therapeutics (BEAM) United States $1.993B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.987B 0.00
Zai Lab (ZLAB) China $1.956B 0.00
NovoCure (NVCR) Jersey $1.953B 0.00
Novavax (NVAX) United States $1.913B 0.00
Fortrea Holdings (FTRE) United States $1.864B 57.78
Galapagos (GLPG) Belgium $1.856B 0.00
Certara (CERT) United States $1.844B 60.32
Akero Therapeutics (AKRO) United States $1.830B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.807B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.734B 0.00
Neumora Therapeutics (NMRA) United States $1.727B 0.00
Arvinas (ARVN) United States $1.713B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.687B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.668B 0.00
MannKind (MNKD) United States $1.658B 60.30
Edgewise Therapeutics (EWTX) United States $1.638B 0.00
Nurix Therapeutics (NRIX) United States $1.574B 0.00
Kura Oncology (KURA) United States $1.508B 0.00
Belite Bio (BLTE) United States $1.494B 0.00
Disc Medicine (IRON) United States $1.492B 0.00
Arcus Biosciences (RCUS) United States $1.477B 0.00
Spyre Therapeutics (SYRE) United States $1.424B 0.00
Dynavax Technologies (DVAX) United States $1.422B 98.64
Longboard Pharmaceuticals (LBPH) United States $1.318B 0.00
ANI Pharmaceuticals (ANIP) United States $1.278B 17.36
Day One Biopharmaceuticals (DAWN) United States $1.273B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.266B 0.00
Tango Therapeutics (TNGX) United States $1.251B 0.00
Cogent Biosciences (COGT) United States $1.230B 0.00
Sana Biotechnology (SANA) United States $1.204B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.181B 0.00
Prothena (PRTA) Ireland $1.115B 0.00
Tyra Biosciences (TYRA) United States $1.114B 0.00
Gyre Therapeutics (GYRE) United States $1.104B 0.00
Phathom Pharmaceuticals (PHAT) United States $1.070B 0.00
Praxis Precision Medicines (PRAX) United States $1.048B 0.00
Vir Biotechnology (VIR) United States $1.045B 0.00
Cullinan Therapeutics (CGEM) United States $1.040B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.039B 0.00
AnaptysBio (ANAB) United States $1.009B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.970B 0.00
Immatics (IMTX) Germany $0.968B 0.00
MiMedx (MDXG) United States $0.937B 26.58
ArriVent BioPharma (AVBP) United States $0.893B 0.00
CARGO Therapeutics (CRGX) United States $0.882B 0.00
Viridian Therapeutics (VRDN) United States $0.861B 0.00
Immunome (IMNM) United States $0.854B 0.00
Arbutus Biopharma (ABUS) United States $0.851B 0.00
Erasca (ERAS) United States $0.845B 0.00
Sinovac Biotech (SVA) China $0.844B 0.00
89BIO (ETNB) United States $0.841B 0.00
Zymeworks (ZYME) United States $0.836B 0.00
Dianthus Therapeutics (DNTH) United States $0.821B 0.00
Castle Biosciences (CSTL) United States $0.814B 0.00
Pliant Therapeutics (PLRX) United States $0.812B 0.00
Stoke Therapeutics (STOK) United States $0.798B 0.00
Abivax SA (ABVX) France $0.777B 0.00
Rapport Therapeutics (RAPP) $0.776B 0.00
Travere Therapeutics (TVTX) United States $0.760B 0.00
Replimune (REPL) United States $0.732B 0.00
Mesoblast (MESO) Australia $0.732B 0.00
Nuvation Bio (NUVB) United States $0.718B 0.00
AbCellera Biologics (ABCL) Canada $0.716B 0.00
Cytek Biosciences (CTKB) United States $0.715B 0.00
Liquidia Technologies (LQDA) United States $0.695B 0.00
Revance Therapeutics (RVNC) United States $0.689B 0.00
Scholar Rock Holding (SRRK) United States $0.687B 0.00
Olema Pharmaceuticals (OLMA) United States $0.677B 0.00
Applied Therapeutics (APLT) United States $0.671B 0.00
Oric Pharmaceuticals (ORIC) United States $0.669B 0.00
LENZ Therapeutics (LENZ) United States $0.657B 0.00
Humacyte (HUMA) United States $0.654B 0.00
WAVE Life Sciences (WVE) Singapore $0.652B 0.00
Astria Therapeutics (ATXS) United States $0.648B 0.00
Adaptive Biotechnologies (ADPT) United States $0.642B 0.00
CureVac (CVAC) Germany $0.638B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.624B 0.00
Annexon (ANNX) United States $0.615B 0.00
IGM Biosciences (IGMS) United States $0.608B 0.00
Mineralys Therapeutics (MLYS) United States $0.594B 0.00
Celcuity (CELC) United States $0.581B 0.00
Avid Bioservices (CDMO) United States $0.574B 0.00
Entrada Therapeutics (TRDA) United States $0.573B 5.20
ITeos Therapeutics (ITOS) United States $0.566B 0.00
REGENXBIO (RGNX) United States $0.562B 0.00
Alumis (ALMS) United States $0.556B 0.00
Q32 Bio (QTTB) United States $0.552B 0.00
Fulcrum Therapeutics (FULC) United States $0.539B 0.00
Allogene Therapeutics (ALLO) United States $0.525B 0.00
PureTech Health (PRTC) United States $0.523B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.507B 0.00
Pharming Group (PHAR) Netherlands $0.500B 0.00
Third Harmonic Bio (THRD) United States $0.490B 0.00
Oculis Holding AG (OCS) Switzerland $0.486B 0.00
Terns Pharmaceuticals (TERN) United States $0.482B 0.00
Anavex Life Sciences (AVXL) United States $0.471B 0.00
Absci (ABSI) United States $0.469B 0.00
Contineum Therapeutics (CTNM) United States $0.456B 0.00
ACELYRIN, INC (SLRN) United States $0.456B 0.00
Prime Medicine (PRME) United States $0.450B 0.00
Neurogene (NGNE) United States $0.447B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.443B 0.00
GH Research (GHRS) Ireland $0.441B 0.00
Alector (ALEC) United States $0.440B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.431B 0.00
GRAIL (GRAL) United States $0.418B 0.00
MaxCyte (MXCT) United States $0.416B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.405B 0.00
Fate Therapeutics (FATE) United States $0.404B 0.00
C4 Therapeutics (CCCC) United States $0.404B 0.00
Emergent Biosolutions (EBS) United States $0.404B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.399B 0.00
Aura Biosciences (AURA) United States $0.388B 0.00
Nkarta (NKTX) United States $0.383B 0.00
Northwest Biotherapeutics (NWBO) United States $0.379B 0.00
G1 Therapeutics (GTHX) United States $0.377B 0.00
Anika Therapeutics (ANIK) United States $0.375B 180.79
Monte Rosa Therapeutics (GLUE) United States $0.369B 0.00
Sutro Biopharma (STRO) United States $0.352B 0.00
Voyager Therapeutics (VYGR) United States $0.346B 22.64
Alto Neuroscience (ANRO) United States $0.343B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.341B 0.00
Ocugen (OCGN) United States $0.340B 0.00
Solid Biosciences (SLDB) United States $0.328B 0.00
Inozyme Pharma (INZY) United States $0.327B 0.00
Kyverna Therapeutics (KYTX) United States $0.327B 0.00
Nautilus Biotechnology (NAUT) United States $0.322B 0.00
Urogen Pharma (URGN) United States $0.322B 0.00
CorMedix Inc (CRMD) United States $0.318B 0.00
Kamada (KMDA) Israel $0.316B 20.37
XOMA Royalty (XOMA) United States $0.312B 0.00
AC Immune (ACIU) Switzerland $0.308B 0.00
Atea Pharmaceuticals (AVIR) United States $0.306B 0.00
Prima BioMed (IMMP) Australia $0.306B 0.00
Alimera Sciences (ALIM) United States $0.301B 0.00
Cartesian Therapeutics (RNAC) United States $0.300B 0.00
TScan Therapeutics (TCRX) United States $0.298B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.296B 0.00
Jasper Therapeutics (JSPR) United States $0.289B 0.00
Artiva Biotherapeutics (ARTV) United States $0.289B 0.00
PepGen (PEPG) United States $0.289B 0.00
EnGene Holdings (ENGN) Canada $0.288B 0.00
Editas Medicine (EDIT) United States $0.288B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.284B 0.00
Biomea Fusion (BMEA) United States $0.276B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.274B 0.00
UniQure (QURE) Netherlands $0.269B 0.00
Tectonic Therapeutic (TECX) United States $0.269B 0.00
Design Therapeutics (DSGN) United States $0.267B 0.00
Poseida Therapeutics (PSTX) United States $0.263B 0.00
ScPharmaceuticals (SCPH) United States $0.260B 0.00
MeiraGTx Holdings (MGTX) United States $0.254B 0.00
Zura Bio (ZURA) United States $0.253B 0.00
Amarin (AMRN) Ireland $0.251B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.250B 0.00
ChromaDex (CDXC) United States $0.248B 0.00
Alpha Teknova (TKNO) United States $0.244B 0.00
Abeona Therapeutics (ABEO) United States $0.244B 0.00
Precigen (PGEN) United States $0.242B 0.00
Rezolute (RZLT) United States $0.242B 0.00
Inhibrx Biosciences (INBX) $0.232B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.230B 0.00
2seventy Bio (TSVT) United States $0.229B 0.00
Trevi Therapeutics (TRVI) United States $0.225B 0.00
Cabaletta Bio (CABA) United States $0.222B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.219B 0.00
Gossamer Bio (GOSS) United States $0.217B 0.00
Scilex Holding (SCLX) United States $0.213B 0.00
Molecular Partners AG (MOLN) Switzerland $0.212B 0.00
GENFIT S.A (GNFT) France $0.209B 0.00
Compass Therapeutics (CMPX) United States $0.205B 0.00
Candel Therapeutics (CADL) United States $0.202B 0.00
Codexis (CDXS) United States $0.199B 0.00
Tenaya Therapeutics (TNYA) United States $0.191B 0.00
XBiotech (XBIT) United States $0.191B 0.00
Innate Pharma S.A (IPHA) France $0.187B 0.00
Oncobiologics (OTLK) United States $0.185B 0.00
Skye Bioscience (SKYE) United States $0.184B 0.00
Greenwich LifeSciences (GLSI) United States $0.176B 0.00
Mersana Therapeutics (MRSN) United States $0.174B 0.00
Opthea (OPT) Australia $0.174B 0.00
Inovio Pharmaceuticals (INO) United States $0.169B 0.00
Shattuck Labs (STTK) United States $0.168B 0.00
Caribou Biosciences (CRBU) United States $0.165B 0.00
BioStem Technologies (BSEM) $0.165B 25.90
DiaMedica Therapeutics (DMAC) United States $0.165B 0.00
Compugen (CGEN) Israel $0.162B 0.00
Sangamo Therapeutics (SGMO) United States $0.156B 0.00
Actuate Therapeutics (ACTU) United States $0.156B 0.00
Generation Bio (GBIO) United States $0.155B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.153B 0.00
Ventyx Biosciences (VTYX) United States $0.153B 0.00
23andMe Holding (ME) United States $0.153B 0.00
Coherus BioSciences (CHRS) United States $0.152B 0.00
Vigil Neuroscience (VIGL) United States $0.149B 0.00
Adherex Technologies (FENC) United States $0.147B 134.25
Rani Therapeutics Holdings (RANI) United States $0.146B 0.00
Adverum Biotechnologies (ADVM) United States $0.142B 0.00
Lifecore Biomedical (LFCR) United States $0.142B 0.00
Elutia (ELUT) United States $0.138B 0.00
Seres Therapeutics (MCRB) United States $0.137B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.136B 0.00
ATyr Pharma (ATYR) United States $0.133B 0.00
Kodiak Sciences (KOD) United States $0.130B 0.00
Adagene (ADAG) China $0.127B 0.00
Cellectis S.A (CLLS) France $0.126B 0.00
Immunic (IMUX) United States $0.123B 0.00
Eton Pharmaceuticals (ETON) United States $0.119B 0.00
Adicet Bio (ACET) United States $0.119B 0.00
INmune Bio (INMB) United States $0.119B 0.00
Akoya Biosciences (AKYA) United States $0.118B 0.00
Inventiva S.A (IVA) France $0.118B 0.00
Repare Therapeutics (RPTX) Canada $0.117B 0.00
Nuvectis Pharma (NVCT) United States $0.115B 0.00
X4 Pharmaceuticals (XFOR) United States $0.114B 0.00
Puma Biotechnology (PBYI) United States $0.113B 12.10
PDS Biotechnology (PDSB) United States $0.110B 0.00
Agenus (AGEN) United States $0.108B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.108B 0.00
ALX Oncology Holdings (ALXO) United States $0.105B 0.00
Cardiff Oncology (CRDF) United States $0.103B 0.00
Annovis Bio (ANVS) United States $0.103B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.102B 0.00
Invivyd (IVVD) United States $0.102B 0.00
Seer (SEER) United States $0.101B 0.00
Genelux (GNLX) United States $0.098B 0.00
Checkpoint Therapeutics (CKPT) United States $0.097B 0.00
Verastem (VSTM) United States $0.097B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.094B 0.00
BioHarvest Sciences (CNVCF) Canada $0.092B 0.00
InflaRx (IFRX) Germany $0.092B 0.00
Coya Therapeutics (COYA) United States $0.092B 0.00
CytomX Therapeutics (CTMX) United States $0.092B 8.43
Instil Bio (TIL) United States $0.092B 0.00
CervoMed (CRVO) United States $0.092B 0.00
Benitec Biopharma (BNTC) United States $0.090B 0.00
BioAtla (BCAB) United States $0.089B 0.00
Werewolf Therapeutics (HOWL) United States $0.089B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.089B 0.00
MediciNova (MNOV) United States $0.088B 0.00
VistaGen Therapeutics (VTGN) United States $0.088B 0.00
Adlai Nortye (ANL) Cayman Islands $0.087B 0.00
Genenta Science S.p.A (GNTA) Italy $0.087B 0.00
HilleVax (HLVX) United States $0.087B 0.00
I-Mab (IMAB) China $0.085B 0.00
Renovaro (RENB) United States $0.084B 0.00
Sagimet Biosciences (SGMT) United States $0.082B 0.00
Cidara Therapeutics (CDTX) United States $0.081B 0.00
Ovid Therapeutics (OVID) United States $0.081B 0.00
Ikena Oncology (IKNA) United States $0.080B 0.00
Galena Biopharma (SLS) United States $0.079B 0.00
Chimerix (CMRX) United States $0.079B 0.00
BeyondSpring (BYSI) United States $0.078B 0.00
DBV Technologies S.A (DBVT) France $0.078B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.078B 0.00
Semper Paratus Acquisition (TVGN) United States $0.077B 0.00
Oncolytics Biotech (ONCY) Canada $0.076B 0.00
Omega Therapeutics (OMGA) United States $0.075B 0.00
Leap Therapeutics (LPTX) United States $0.075B 0.00
Spero Therapeutics (SPRO) United States $0.072B 3.24
Boundless Bio (BOLD) United States $0.071B 0.00
Precision BioSciences (DTIL) United States $0.070B 0.00
Entera Bio (ENTX) Israel $0.070B 0.00
Clearside Biomedical (CLSD) United States $0.069B 0.00
TELA Bio (TELA) United States $0.069B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.068B 0.00
Rapt Therapeutics (RAPT) United States $0.067B 0.00
Connect Biopharma Holdings (CNTB) United States $0.066B 0.00
FibroBiologics (FBLG) United States $0.065B 0.00
Aileron Therapeutics (ALRN) United States $0.063B 0.00
Celularity (CELU) United States $0.062B 0.00
Bluebird Bio (BLUE) United States $0.062B 0.00
Imunon (IMNN) United States $0.062B 0.00
HOOKIPA Pharma (HOOK) United States $0.062B 0.00
Allakos (ALLK) United States $0.061B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.060B 0.00
Kronos Bio (KRON) United States $0.059B 0.00
IO Biotech (IOBT) Denmark $0.059B 0.00
Intensity Therapeutics (INTS) United States $0.059B 0.00
Affimed (AFMD) Germany $0.058B 0.00
Immix Biopharma (IMMX) United States $0.058B 0.00
Enzo Biochem (ENZ) United States $0.057B 0.00
Theratechnologies (THTX) Canada $0.057B 0.00
Vor Biopharma (VOR) $0.056B 0.00
Aerovate Therapeutics (AVTE) United States $0.056B 0.00
CalciMedica (CALC) United States $0.055B 0.00
Gritstone Bio (GRTS) United States $0.055B 0.00
Lexaria Bioscience (LEXX) Canada $0.052B 0.00
Atara Biotherapeutics (ATRA) United States $0.049B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.048B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.047B 0.00
Rallybio (RLYB) United States $0.046B 0.00
VTv Therapeutics (VTVT) United States $0.046B 0.00
Aadi Bioscience (AADI) United States $0.044B 0.00
Elicio Therapeutics (ELTX) United States $0.043B 0.00
Kezar Life Sciences (KZR) United States $0.042B 0.00
Fortress Biotech (FBIO) United States $0.042B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.041B 0.00
LakeShore Biopharma (LSB) China $0.041B 0.00
Syros Pharmaceuticals (SYRS) United States $0.041B 0.00
Promis Neurosciences (PMN) Canada $0.041B 0.00
Clene (CLNN) United States $0.041B 0.00
NextCure (NXTC) United States $0.040B 0.00
Passage Bio (PASG) United States $0.040B 0.00
Bionano Genomics (BNGO) United States $0.039B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.039B 0.00
Estrella Immunopharma (ESLA) United States $0.039B 0.00
Elevation Oncology (ELEV) United States $0.038B 0.00
Aligos Therapeutics (ALGS) United States $0.038B 0.00
Lantern Pharma (LTRN) United States $0.038B 0.00
Dyadic (DYAI) United States $0.037B 0.00
Ocean Biomedical (OCEA) United States $0.036B 0.00
OKYO Pharma (OKYO) $0.036B 0.00
Immuneering (IMRX) United States $0.035B 0.00
Equillium (EQ) United States $0.035B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.035B 0.00
Xilio Therapeutics (XLO) United States $0.034B 0.00
Eyenovia (EYEN) United States $0.033B 0.00
Chemomab Therapeutics (CMMB) Israel $0.033B 0.00
Ocuphire Pharma (OCUP) United States $0.032B 0.00
MiNK Therapeutics (INKT) United States $0.031B 0.00
Longeveron (LGVN) United States $0.031B 0.00
Curis (CRIS) United States $0.031B 0.00
Lumos Pharma (LUMO) United States $0.031B 0.00
AN2 Therapeutics (ANTX) United States $0.031B 0.00
Cue Biopharma (CUE) United States $0.031B 0.00
Quince Therapeutics (QNCX) United States $0.030B 0.00
Dare Bioscience (DARE) United States $0.029B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.029B 0.00
Pluri (PLUR) Israel $0.028B 0.00
Orgenesis (ORGS) United States $0.028B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.028B 0.00
Lisata Therapeutics (LSTA) United States $0.027B 0.00
KALA BIO (KALA) United States $0.027B 0.00
SAB Biotherapeutics (SABS) United States $0.027B 0.00
UNITY Biotechnology (UBX) United States $0.026B 0.00
Bolt Biotherapeutics (BOLT) United States $0.025B 0.00
Femasys (FEMY) United States $0.024B 0.00
Cognition Therapeutics (CGTX) United States $0.024B 0.00
BioXcel Therapeutics (BTAI) United States $0.024B 0.00
RenovoRx (RNXT) United States $0.024B 0.00
Biora Therapeutics (BIOR) United States $0.023B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.023B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.023B 0.00
Vincerx Pharma (VINC) United States $0.022B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.022B 0.00
Athira Pharma (ATHA) United States $0.022B 0.00
HCW Biologics (HCWB) United States $0.021B 0.00
GeoVax Labs (GOVX) United States $0.020B 0.00
Beyond Air (XAIR) United States $0.020B 0.00
NKGen Biotech (NKGN) United States $0.020B 0.00
Cyclo Therapeutics (CYTH) United States $0.020B 0.00
Spruce Biosciences (SPRB) United States $0.019B 0.00
BioAffinity Technologies (BIAF) United States $0.019B 0.00
Aprea Therapeutics (APRE) United States $0.018B 0.00
Cocrystal Pharma (COCP) United States $0.018B 0.00
Evaxion Biotech (EVAX) Denmark $0.018B 0.00
Cara Therapeutics (CARA) United States $0.018B 0.00
Synlogic (SYBX) United States $0.017B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.016B 0.00
IN8bio (INAB) United States $0.016B 0.00
Turnstone Biologics (TSBX) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.015B 0.00
Sensei Biotherapeutics (SNSE) United States $0.015B 0.00
Aytu BioPharma (AYTU) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
ANEW Medical (WENA) United States $0.014B 0.00
Senti Biosciences (SNTI) United States $0.014B 0.00
Tenax Therapeutics (TENX) United States $0.013B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.013B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.013B 0.00
BRIACELL THERAP (BCTX) Canada $0.013B 0.00
Evogene (EVGN) Israel $0.013B 0.00
Galecto (GLTO) Denmark $0.012B 0.00
Apollomics (APLM) United States $0.011B 0.00
Forte Biosciences (FBRX) United States $0.011B 0.00
Purple Biotech (PPBT) Israel $0.011B 0.00
Novogen (KZIA) Australia $0.011B 0.00
Mustang Bio (MBIO) United States $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.010B 0.00
Carmell (CTCX) United States $0.010B 0.00
Soligenix (SNGX) United States $0.009B 0.00
Kintara Therapeutics (KTRA) United States $0.009B 0.00
Vaccinex (VCNX) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Eterna Therapeutics (ERNA) United States $0.009B 0.00
Hoth Therapeutics (HOTH) United States $0.009B 0.00
Cadrenal Therapeutics (CVKD) United States $0.009B 0.00
Monopar Therapeutics (MNPR) United States $0.009B 0.00
Silexion Therapeutics Corp (SLXN) United States $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Organovo Holdings (ONVO) United States $0.008B 0.00
Kineta (KA) United States $0.008B 0.00
ABVC BioPharma (ABVC) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.007B 0.00
NuCana (NCNA) United Kingdom $0.007B 0.00
Telesis Bio (TBIO) United States $0.007B 0.00
COSCIENS Biopharma (CSCI) Canada $0.007B 0.00
Moleculin Biotech (MBRX) United States $0.007B 0.00
Allarity Therapeutics (ALLR) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Aptose Biosciences (APTO) Canada $0.007B 0.00
TFF Pharmaceuticals (TFFP) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Elevai Labs (ELAB) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Cingulate (CING) United States $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
BioCardia (BCDA) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Virios Therapeutics (VIRI) United States $0.005B 0.00
Notable Labs (NTBL) United States $0.005B 0.00
Bionomics (BNOX) Australia $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Quantum Biopharma (QNTM) Canada $0.005B 0.00
Enveric Biosciences (ENVB) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Citius Oncology (CTOR) United States $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
Trevena (TRVN) United States $0.004B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Ensysce Biosciences (ENSC) United States $0.003B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
Exicure (XCUR) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Alzamend Neuro (ALZN) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Seelos Therapeutics (SEEL) United States $0.001B 0.00
Entero Therapeutics (ENTO) United States $0.001B 0.00
GENPREX (GNPX) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00